Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery
Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Sep 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the best way to manage drainage after a specific type of lung surgery called uniportal video-assisted thoracoscopic surgery (VATS). The study compares two methods: a small, flexible pigtail catheter and a larger chest tube. Researchers want to see which option helps reduce pain, improves recovery, and lowers the need for pain medications after surgery.
To participate, you need to be an adult patient scheduled for elective uniportal VATS lobectomy, which is a procedure to remove part of the lung. However, if you have certain health issues, are significantly overweight, or have a history of chronic pain requiring regular opioid use, you may not be eligible. If you join the trial, you’ll be monitored closely to see how well the drainage method works for you, and you'll receive support throughout your recovery. This study is currently looking for participants, and your involvement could help improve care for future patients undergoing similar surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - eighty consecutive adult patients undergoing elective uniportal VATS lobectomy
- Exclusion Criteria:
- • - patient refusal, body mass index \> 27 kg/m2, American society of anesthesiologists (ASA) grade above 3, contraindication to nerve block, allergy to analgesic agents, regular opioid used for chronic pain prior to this time surgery, anticipating postoperative patient control analgesia (PCA) before operation, surgeon's decision for exclusion during operation, conversion to thoracotomy or multiportal VATS procedure, postoperative intubation, postoperative intensive care unit admission.
About National Cheng Kung University Hospital
National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported